Article

Early refills now allowed in New Jersey

New Jersey has enacted legislation that requires insurance companies and health plans to provide coverage for the early refill of prescription eye drops at 70% of the predicted days of use.

 

Trenton, NJ-The state of New Jersey has enacted legislation that requires insurance companies and health plans to provide coverage for the early refill of prescription eye drops at 70% of the predicted days of use.

This important patient safety legislation would ensure continuity of therapy for patients with eye and sight problems by allowing the uninterrupted administration of necessary eye medication for patients who are in need of early refills. The New Jersey Academy of Ophthalmology (NJAO), spearheaded by President Cecily Lesko MD, was at the forefront of this legislation, advocating on behalf of New Jersey patients.

“Many diseases of the eye are treated with chronic therapy through use of medications,” said Dr. Lesko. “Glaucoma is the most common. Left untreated, it is one of the leading causes of blindness. With this effort and outcome, proper treatment remains available to more patients who will benefit personally and directly through the treasured gift of sight.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.